EP
Eversept Partners’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-102,661
| Closed | -$6.73M | – | 58 |
|
|
2024
Q4 | $6.73M | Buy |
+102,661
| New | +$6.73M | 0.6% | 31 |
|
|
2022
Q3 | – | Sell |
-1,020,329
| Closed | -$67.4M | – | 65 |
|
|
2022
Q2 | $67.4M | Buy |
1,020,329
+275,066
| +37% | +$18.2M | 4.79% | 5 |
|
|
2022
Q1 | $49.4M | Sell |
745,263
-203,961
| -21% | -$13.5M | 3.8% | 6 |
|
|
2021
Q4 | $55.3M | Buy |
949,224
+58,416
| +7% | +$3.4M | 3.53% | 5 |
|
|
2021
Q3 | $53.5M | Sell |
890,808
-94,914
| -10% | -$5.7M | 3.7% | 7 |
|
|
2021
Q2 | $59M | Sell |
985,722
-6,593
| -0.7% | -$395K | 3.94% | 5 |
|
|
2021
Q1 | $49.3M | Buy |
992,315
+139,884
| +16% | +$6.96M | 3.71% | 7 |
|
|
2020
Q4 | $42.6M | Buy |
852,431
+791,495
| +1,299% | +$39.6M | 5% | 5 |
|
|
2020
Q3 | $3.34M | Sell |
60,936
-501,215
| -89% | -$27.5M | 0.74% | 29 |
|
|
2020
Q2 | $29.7M | Buy |
562,151
+209,600
| +59% | +$11.1M | 4.08% | 6 |
|
|
2020
Q1 | $15.7M | Buy |
352,551
+211,989
| +151% | +$9.47M | 3.91% | 9 |
|
|
2019
Q4 | $7.01M | Buy |
+140,562
| New | +$7.01M | 1.24% | 21 |
|